Stephen G. Juelsgaard is Secretary & EVP at GENENTECH INC (DNA). They have made 12 open-market trades across 1 company since 2006, most recently 2009-03-26.
CIK 0001214125
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNA | 5,967 | $61K |
Shares reported on the most recent Form 4, priced at the 2008-07-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNA | SELL | 2008-07-18 | 2008-07-22 | $82.12 | $1.7M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-07-18 | 2008-07-22 | $81.97 | $352K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-07-16 | 2008-07-18 | $79.31 | $1.3M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-07-16 | 2008-07-18 | $79.32 | $664K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-02-27 | 2008-02-29 | $77.00 | $4.7M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-11-09 | 2007-11-13 | $75.00 | $3.8M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-01-12 | 2007-01-17 | $87.19 | $1.8M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-01-12 | 2007-01-17 | $86.84 | $1.5M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-01-12 | 2007-01-17 | $86.76 | $920K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-01-12 | 2007-01-17 | $86.57 | $105K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2006-08-18 | 2006-08-21 | $81.86 | $426K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2006-08-18 | 2006-08-21 | $82.06 | $1.2M | -3.3% | -4.6% | -4.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.